TY - JOUR
T1 - Prognostic factors for VTE and bleeding in hospitalized medical patients
T2 - A systematic review and meta-analysis
AU - Darzi, Andrea J.
AU - Karam, Samer G.
AU - Charide, Rana
AU - Etxeandia-Ikobaltzeta, Itziar
AU - Cushman, Mary
AU - Gould, Michael K.
AU - Mbuagbaw, Lawrence
AU - Spencer, Frederick A.
AU - Spyropoulos, Alex C.
AU - Streiff, Michael B.
AU - Woller, Scott
AU - Zakai, Neil A.
AU - Germini, Federico
AU - Rigoni, Marta
AU - Agarwal, Arnav
AU - Morsi, Rami Z.
AU - Iorio, Alfonso
AU - Akl, Elie A.
AU - Schünemann, Holger J.
N1 - Funding Information:
This work was supported by a subcontract (200-2016-92458) from the US Centers for Disease Control and Prevention (CDC), through Karna LLC.
Publisher Copyright:
© 2020 American Society of Hematology. All rights reserved.
PY - 2020/5
Y1 - 2020/5
N2 - There may be many predictors of venous thromboembolism (VTE) and bleeding in hospitalized medical patients, but until now, systematic reviews and assessments of the certainty of the evidence have not been published. We conducted a systematic review to identify prognostic factors for VTE and bleeding in hospitalized medical patients and searched Medline and EMBASE from inception through May 2018. We considered studies that identified potential prognostic factors for VTE and bleeding in hospitalized adult medical patients. Reviewers extracted data in duplicate and independently and assessed the certainty of the evidence using the Grading of Recommendations Assessment, Development, and Evaluation approach. Of 69 410 citations, we included 17 studies in our analysis: 14 that reported on VTE, and 3 that reported on bleeding. For VTE, moderate-certainty evidence showed a probable association with older age; elevated C-reactive protein (CRP), D-dimer, and fibrinogen levels; tachycardia; thrombocytosis; leukocytosis; fever; leg edema; lower Barthel Index (BI) score; immobility; paresis; previous history of VTE; thrombophilia; malignancy; critical illness; and infections. For bleeding, moderate-certainty evidence showed a probable association with older age, sex, anemia, obesity, low hemoglobin, gastroduodenal ulcers, rehospitalization, critical illness, thrombocytopenia, blood dyscrasias, hepatic disease, renal failure, antithrombotic medication, and presence of a central venous catheter. Elevated CRP, a lower BI, a history of malignancy, and elevated heart rate are not included in most VTE risk assessment models. This study informs risk prediction in the management of hospitalized medical patients for VTE and bleeding; it also informs guidelines for VTE prevention and future research.
AB - There may be many predictors of venous thromboembolism (VTE) and bleeding in hospitalized medical patients, but until now, systematic reviews and assessments of the certainty of the evidence have not been published. We conducted a systematic review to identify prognostic factors for VTE and bleeding in hospitalized medical patients and searched Medline and EMBASE from inception through May 2018. We considered studies that identified potential prognostic factors for VTE and bleeding in hospitalized adult medical patients. Reviewers extracted data in duplicate and independently and assessed the certainty of the evidence using the Grading of Recommendations Assessment, Development, and Evaluation approach. Of 69 410 citations, we included 17 studies in our analysis: 14 that reported on VTE, and 3 that reported on bleeding. For VTE, moderate-certainty evidence showed a probable association with older age; elevated C-reactive protein (CRP), D-dimer, and fibrinogen levels; tachycardia; thrombocytosis; leukocytosis; fever; leg edema; lower Barthel Index (BI) score; immobility; paresis; previous history of VTE; thrombophilia; malignancy; critical illness; and infections. For bleeding, moderate-certainty evidence showed a probable association with older age, sex, anemia, obesity, low hemoglobin, gastroduodenal ulcers, rehospitalization, critical illness, thrombocytopenia, blood dyscrasias, hepatic disease, renal failure, antithrombotic medication, and presence of a central venous catheter. Elevated CRP, a lower BI, a history of malignancy, and elevated heart rate are not included in most VTE risk assessment models. This study informs risk prediction in the management of hospitalized medical patients for VTE and bleeding; it also informs guidelines for VTE prevention and future research.
UR - http://www.scopus.com/inward/record.url?scp=85084784902&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084784902&partnerID=8YFLogxK
U2 - 10.1182/BLOOD.2019003603
DO - 10.1182/BLOOD.2019003603
M3 - Review article
C2 - 32092132
AN - SCOPUS:85084784902
SN - 0006-4971
VL - 135
SP - 1788
EP - 1810
JO - Blood
JF - Blood
IS - 20
ER -